Skip to main content
. 2022 Jan 7;12(1):e049933. doi: 10.1136/bmjopen-2021-049933

Figure 4.

Figure 4

Baseline antithrombotic treatment distribution by Healthcare Access and Quality (HAQ) index.1 1 As HAQ index is a country measure, all patients enrolled within a specific country are assigned the same HAQ index. HAQ index of OAC+AP or AP only: <70=46.7%; 70–79=52.5%; 80–89=30.1%; ≥90=28.6%. NOAC, AP, antiplatelet; NOAC, non-vitamin K antagonist oral anticoagulant; VKA, vitamin K antagonist.